title: Biafine topical emulsion accelerates excisional and burn wound healing in mice.
abstract: Macrophages play a fundamental role in wound healing; therefore, employing a strategy that enhances macrophage recruitment would be ideal. It was previously suggested that the mechanism by which Biafine topical emulsion improves wound healing is via enhanced macrophage infiltration into the wound bed. The purpose of this study was to confirm this observation through gross and histologic assessments of wound healing using murine full-thickness excisional and burn wound models, and compare to common standards, Vaseline and silver sulfadiazine (SSD). Full-thickness excisional and burn wounds were created on two groups of 60 mice. In the excisional arm, mice were divided into untreated control, Biafine, and Vaseline groups. In the burn arm, mice were divided into untreated control, Biafine, and SSD groups. Daily treatments were administered and healing was measured over time. Wound tissue was excised and stained to appropriately visualize morphology, collagen, macrophages, and neutrophils. Collagen deposition was measured and cell counts were performed. Biafine enhanced wound healing in murine full-thickness excisional and burn wounds compared to control, and surpassed Vaseline and SSD in respective wound types. Biafine treatment accelerated wound closure clinically, with greater epidermal/dermal maturity, granulation tissue formation, and collagen quality and arrangement compared to other groups histologically. Biafine application was associated with greater macrophage and lower neutrophil infiltration at earlier stages of healing when compared to other study groups. In conclusion, Biafine can be considered an alternative topical therapy for full-thickness excisional and burn wounds, owing to its advantageous biologically based wound healing properties.
authors: Division of Dermatology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, 111 E. 210th Street, Bronx, New York, 10467, USA.
authors: Aimee E
authors: AE
authors: Krausz
authors: Brandon L
authors: BL
authors: Adler
authors: Angelo
authors: A
authors: Landriscina
authors: Jamie M
authors: JM
authors: Rosen
authors: Tagai
authors: T
authors: Musaev
authors: Joshua D
authors: JD
authors: Nosanchuk
authors: Adam J
authors: AJ
authors: Friedman
mesh_terms: D000287:Administration, Topical; D000818:Animals; D002056:Burns / Q000188:drug therapy*; D004655:Emulsions / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D008055:Lipids / Q000008:administration & dosage / Q000627:therapeutic use*; D051379:Mice; D008807:Mice, Inbred BALB C; D013997:Time Factors; D014945:Wound Healing / Q000187:drug effects*
chemical_list: C423724:Biafine; D004655:Emulsions; D008055:Lipids